Search results for "Highlights"
Incretin-based drugs not associated with greater heart failure hospitalization risk than other drug combos in retrospective study
Researchers compared patients taking dipeptidyl peptidase 4 (DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) analogues to those taking 2 or more oral antidiabetic drugs.
https://diabetes.acponline.org/archives/2016/04/08/3.htm
8 Apr 2016
SGLT2 inhibitors may protect against some major cardiovascular events
Sodium-glucose cotransporter-2 (SGLT2) inhibitors were associated with lower risk of major adverse cardiovascular events and death from any cause, but there was no clear effect on nonfatal myocardial infarction and researchers noted an adverse effect for nonfatal stroke.
https://diabetes.acponline.org/archives/2016/04/08/1.htm
8 Apr 2016
Adding DPP-4s to sulfonylureas may increase hypoglycemia risk
The review of 10 randomized controlled trials found 1 excess case of hypoglycemia for every 17 patients in the first 6 months of combined treatment.
https://diabetes.acponline.org/archives/2016/05/13/2.htm
13 May 2016
1-hour glucose value may predict mortality risk
A 1-hour glucose value above 155 mg/dL predicted mortality even when the 2-hour glucose value was below 140 mg/dL, according to the 33-year study.
https://diabetes.acponline.org/archives/2016/05/13/3.htm
13 May 2016
Online reporting of blood glucose may lower HbA1c in diabetes patients on oral meds
The results suggest that highly adherent diabetes patients who self-monitor their blood glucose could benefit from reporting their results, study authors concluded.
https://diabetes.acponline.org/archives/2016/05/13/1.htm
13 May 2016
Intensive glycemic treatment may be common, doubles risk of hypoglycemia
Intensive treatment was defined as use of more glucose-lowering medications than recommended by practice guidelines and was found in 18.7% of clinically complex Medicare patients.
https://diabetes.acponline.org/archives/2016/06/10/2.htm
10 Jun 2016
Excess mortality examined in older patients with diabetes
Excess mortality associated with diabetes was highest in patients younger than age 75 who had had diabetes for a longer time period, with the relative hazard highest in women, a study found.
https://diabetes.acponline.org/archives/2016/06/10/3.htm
10 Jun 2016
New clinical guidelines recommend bariatric surgery for obese patients with type 2 diabetes
Bariatric surgery should be recommended for type 2 diabetes patients with class III obesity, regardless of glycemic control, and those with class II obesity who have inadequately controlled hyperglycemia despite lifestyle and optimal medical therapy, the guidelines said.
https://diabetes.acponline.org/archives/2016/06/10/1.htm
10 Jun 2016
Liraglutide may offer high-risk patients protection from CV events, death, study finds
The Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) trial, which was funded by Novo Nordisk and the National Institutes of Health, randomized 9,340 patients ages 50 years and older to 1.8 mg of liraglutide per day via injection or placebo in addition to standard care.
https://diabetes.acponline.org/archives/2016/07/15/1.htm
15 Jul 2016
Socioeconomic status appears linked to mortality in patients with type 2 diabetes
The study looked at data from the Sweden National Diabetes Register to determine what patient characteristics were related to all-cause mortality or death from cardiovascular-, diabetes-, or cancer-related causes.
https://diabetes.acponline.org/archives/2016/07/15/3.htm
15 Jul 2016